Coronavirus Disease 2019 (COVID-19) Impact on Clinical Trials in 2021 and the Potential Move Toward Decentralized Clinical Trials - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Coronavirus Disease 2019 (COVID-19) Impact on Clinical Trials, 2021 Update" report has been added to ResearchAndMarkets.com's offering.

This report gives an important update to the previous year with an expert analysis on how COVID-19 is impacting clinical trials and the potential move toward decentralized clinical trials. Findings are based on a survey conducted with 154 respondents from around the world that belonged to Pharma/Biotech, Government/Academic Institutions, CROs, CMOs, or other contract service providers.

The report includes

• Study Design and Key Findings.
• Primary Concerns, which include business concerns, clinical trial concerns for decentralized clinical trials and addressing trial disruption.
• Movement Toward Decentralized Trials, including pre and post pandemic decentralized clinical trials use, future movement toward using decentralized clinical trials and cost comparison.
• Challenges Facing Decentralized Trials, which explores the biggest challenges, changes, considerations and risk deviations for decentralized clinical trials.

Scope

• A total of 154 The Publisher Pharma clients and prospects from the around the world participated in the seven-minute survey, which was fielded from August 3, 2021 to September 2, 2021.
• This report includes and is based around industry opinions on COVID-19's impact on clinical trials and the use of decentralized clinical trials.

Key Topics Covered:

1 Study Design

1.1 Background

1.2 Objectives and Design

1.3 Respondent Mix

1.4 Respondent Profiles

2 Key Findings

3 Primary Business and Clinical Trial Concerns

3.1 Primary Business Concerns

3.2 Primary Clinical Trial Concerns

3.3 Clinical Trial Disruptions

3.4 Addressing Clinical Trial Disruptions

4 Movement Toward Decentralized Trials

3.1 Pre-pandemic Decentralized Trials Use

3.2 Post-pandemic Decentralized Trials Use

3.3 Future Movement Toward Decentralized Clinical Trial Use

3.4 Cost Comparison

4 Challenges Facing Decentralized Trials

4.1 Biggest Challenges

4.2 Biggest Changes

4.3 Biggest Considerations

4.4 Risk Deviations

5 Summary

For more information about this report visit https://www.researchandmarkets.com/r/jnulsb